Delivery Order SPE2DB20D2014-SPE2DB26FA22E
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,603.16 on July 30, 2025, for the supply of Proctofoam 10GM. This firm fixed price, non-competitive delivery order is set to be completed by July 31, 2025, and falls under a child contract associated with the Defense Logistics Agency's Medical Supply Chain. The place of performance is located in Conshohocken, Pennsylvania, reflecting...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $2,515.44 by the Defense Logistics Agency's Medical Supply Chain on July 28, 2025, for Proctofoam-HC 1%-1% Foam in 10-gram units. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 29, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery order represents a child contract...
- The Defense Logistics Agency awarded a delivery order valued at $2,681.58 to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% Foam, a topical pharmaceutical product in a 10-gram formulation. This non-competitive delivery order, issued on August 13, 2025, with an ultimate completion date of August 14, 2025, represents a firm fixed price contract. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. As a child...
- The Defense Logistics Agency awarded a $1,643.05 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Proctofoam-HC 1%-1% foam in 10-gram units. The order, which is not set-aside, is scheduled for completion by September 26, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's existing prime indefinite delivery contract with DLA Troop...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for Proctofoam-HC 1%-1% Foam (10gm), a pharmaceutical product with a ceiling value of $7,073.70. This firm fixed price delivery order, with an ultimate completion date of September 19, 2025, represents a non-competitive set-aside contract and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award is a child...
- The Defense Logistics Agency awarded a $1,637.16 delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for Proctofoam-HC 1%-1% Foam in a 10-gram unit. This is a firm fixed-price, non-set-aside contract with a completion date of August 26, 2025, and represents a child delivery order under AmerisourceBergen's broader pharmaceutical supply agreements with the agency. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This award is...
- The Defense Logistics Agency awarded a $1,135.36 firm fixed-price delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for Proctofoam-HC 1%-1% Foam in 10-gram units. This is a non-set-aside competitive award with an ultimate completion date of October 31, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- Amerisourcebergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania, has been awarded a $4,698.24 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide PROCTOFOAM-HC 1%-1% FOAM 10GM pharmaceutical products. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025....
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a competitively-bid delivery order valued at $8,804.04 by the Defense Medical Supply Chain on May 23, 2025, for the procurement of Proctofoam 10GM 1S, a topical pharmaceutical product. The delivery order represents a firm fixed-price contract with an ultimate completion date of May 27, 2025, and carries no set-aside designation. This award is structured as a child contract, likely issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,141.16 to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% Foam in a 10-gram unit on April 22, 2025, with an ultimate completion date of April 23, 2025. This competitive, non-set-aside award utilizes firm fixed-price pricing and represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The product will be delivered to the company's corporate office location in...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB26FA22EDelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a $2,432.56 delivery order from the Defense Logistics Agency (DLA) on October 29, 2025, for Proctofoam-HC 1%-1% Foam in a 10-gram unit. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of October 30, 2025. The delivery order will be performed in Conshohocken, Pennsylvania, and represents a continuation of AmerisourceBergen's extensive pharmaceutical supply relationship with the federal government's medical procurement systems. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products, medical devices, vaccines, and specialized healthcare commodities to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. The company's consistent receipt of competitive, non-set-aside awards demonstrates its established capability to meet federal medical supply requirements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 10/29/25 |